SL
Seth Lieblich
Principal at 8VC
SL
Seth Lieblich
Principal at 8VC
San Francisco, California
Overview
Seth Lieblich is a Principal at 8VC in San Francisco, California, with a background in co-founding Latus Bio and serving as Chief Operating Officer at Protomer Technologies. He holds a Doctor of Philosophy from Caltech and has a strong track record in the BioTech sector, focusing on Series A and Seed stage investments in the San Francisco Bay Area.
Work Experience
Principal
2021 - Current
8VC transform the technology infrastructure behind many industries.
Co-founder and CBO
2022 - 2023
Latus Bio focuses on developing innovative gene therapy candidates using precision delivery to enhance the lives of patients.
Raised $54,000,000.00 from The Children's Hospital of Philadelphia, Modi Ventures, 8VC, Gaingels, Samsung Life Science Fund, DCVC Bio and Ben Franklin Technology Partners.
Business Development
2018 - 2021
Search & Evaluation and Transactions for Academic Partnerships, Platform Technologies, Collaborations and Licensing
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
Raised $28,500,000,000.00 from Citibank and Bank of America.
Associate Consultant
2018 - 2018
Chief Operating Officer and Co-Founder
2017 - 2018
Education
Doctor of Philosophy - PhD
2010 - 2017